The odds of a Fed-induced recession have been soaring amid sky-high inflation, resilient spending, and robust job data. Investors’ sentiments are simultaneously being hampered. Given that the volatilities could persist in the upcoming months, let us probe into stocks such as Novo Nordisk A/S (NVO), Altria Group, Inc. (MO), and Cardinal Health, Inc. (CAH).
The Fed’s efforts to tame the stubbornly high inflation will likely continue in the upcoming months of 2023 on the backs of stronger-than-anticipated job growth and resilient consumer spending despite high prices. A bout of anxiety has set in among investors post the Fed’s hawkish comments related to rate hikes.
